Position in VTRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$94,138,894
-$14,398,770 QoQ
Shares Held
5,928,142
-26.2% QoQ
Ownership
0.516%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#30
of 1,020 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Pacer Advisors, Inc. holds $406,344,526 across 19 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (23.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,556,307 | $111,836,221 | |
| 2 | VTRS |
Viatris Inc
This page
|
5,928,142 | $94,138,894 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
155,398 | $84,199,298 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
419,770 | $70,748,035 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
277,282 | $10,037,608 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
186,134 | $8,798,554 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
81,486 | $6,745,411 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
212,814 | $5,399,091 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $94,138,894 | 5,928,142 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $108,537,664 | 8,033,876 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,137,357 | 91,354 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $1,030,590 | 104,100 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $83,561,072 | 9,357,343 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $98,929,059 | 11,358,101 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $437,656,119 | 35,153,102 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1,332,944 | 114,810 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $407,251,393 | 38,311,514 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $315,397,261 | 26,415,181 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $225,840,524 | 20,853,234 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $154,447,454 | 15,664,042 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $156,304,724 | 15,661,796 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $139,670,019 | 14,518,713 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $136,257,466 | 12,242,360 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $79,559,189 | 9,337,933 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $87,318,480 | 8,339,874 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $52,477,786 | 4,823,326 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $1,093,751 | 80,839 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,546,326 | 114,120 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $1,459,466 | 102,132 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $947,263 | 67,807 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $1,401,283 | 74,775 | Shares | Sole | 2021-01-20 | |
| No filing history on record for this holder in this stock. | ||||||